Cinnarizine/dimenhydrinate, sold under the brand name Cizinate among others is a fixed-dose combination medication for the treatment of vertigo in adults. It contains cinnarizine and dimenhydrinate. It is taken by mouth.
It was approved for medical use in Australia in December 2018.
References
Further reading
- Hahn A, Novotný M, Shotekov PM, Cirek Z, Bognar-Steinberg I, Baumann W (2011). "Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study". Clin Drug Investig. 31 (6): 371–83. doi:10.2165/11588920-000000000-00000. PMID 21401214. S2CID 26720922.
- Scholtz AW, Ilgner J, Loader B, Pritschow BW, Weisshaar G (May 2016). "Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice". Wien. Klin. Wochenschr. 128 (9–10): 341–7. doi:10.1007/s00508-015-0905-5. PMC 4875047. PMID 26659910.9–10&rft.pages=341-7&rft.date=2016-05&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875047#id-name=PMC&rft_id=info:pmid/26659910&rft_id=info:doi/10.1007/s00508-015-0905-5&rft.aulast=Scholtz&rft.aufirst=AW&rft.au=Ilgner, J&rft.au=Loader, B&rft.au=Pritschow, BW&rft.au=Weisshaar, G&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875047&rfr_id=info:sid/en.wikipedia.org:Cinnarizine/dimenhydrinate">
- Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ (June 2004). "Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study". Clin Ther. 26 (6): 866–77. doi:10.1016/s0149-2918(04)90130-0. PMID 15262457.
External links
- "Cinnarizine". Drug Information Portal. U.S. National Library of Medicine.
- "Dimenhydrinate". Drug Information Portal. U.S. National Library of Medicine.
